Evaluating paclitaxel hypersensitivity reaction rates with cetirizine premedication at a large academic cancer center
Journal of Oncology Pharmacy Practice
Published online on October 16, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionPaclitaxel is associated with hypersensitivity reactions (HSRs) in up to 40% of patients, primarily during the first two lifetime infusions. Standard premedication with diphenhydramine, dexamethasone, and famotidine as recommended by the ...
IntroductionPaclitaxel is associated with hypersensitivity reactions (HSRs) in up to 40% of patients, primarily during the first two lifetime infusions. Standard premedication with diphenhydramine, dexamethasone, and famotidine as recommended by the ...